PharmiWeb.com - Global Pharma News & Resources
19-Jul-2019

Anatomic Pathology Market Will Grow 6.0% to a Record $ 24 Billion by 2026

The Global Anatomic Pathology Market Size to touch valuation around USD 24 billion by 2026, this market is anticipated to grow with 6.0% CAGR during the forecast time period 2019 to 2026. Acumen Research and Consulting recently published a report titled ldquo;Anatomic Pathology Market (By Product and Service: Consumables [Reagents amp; Antibodies, Probes amp; Kits, Others], Instruments [Tissue processors, Automatic Stainers, Microtomes amp; Cryostat, Others], Services; By Application: Drug Discovery amp; Development, Disease Diagnosis, Others; By End-use: Hospitals, Diagnostic Laboratories, Research Laboratories, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026rdquo;.

Technology is expected to boost the adoption rate of sophisticated anatomical pathological devices in tools and protocols used during anatomical pathology. The integration of healthcare informatics norms by improving effectiveness and reducing expenses is a driving factor for the industry. Market actors cooperate in pathology laboratory renovation with the incorporation of innovative models for diagnosing diseases. This in turn speeds up investments in pathological machinery upgrading.

Thermo Fisher and Leica Microsystems worked together in April 2018 to develop an integrated workflow for studying cryo-tomography. Within the framework of this partnership, the businesses combined their current technology to provide improved microscopic alternatives that are user friendly and reliable, allowing scientists to obtain insights into biological procedures.

The anatomical pathology market is supported by pathology-trainee programs provided by government and private bodies to pathologists. Some of the associations which started various training programs and exams for the evaluation of a pathologist's skill and understanding are the Royal College of Pathologists and the General Medical Council and the Association of Anatomical Pathology Technology.

Download Free Sample Report Pages for Better Understanding at https://www.acumenresearchandconsulting.com/request-sample/1525

Key Highlights

The Diagnostics Laboratories segment is anticipated to achieve the fastest growth rate with technological developments in tools to minimize the danger of mistakes by integrating novel designs.

The dominant income share of the consumables has been ascribed to high availability, low costs and frequent buy rates of consumables such as reagents and samples.

The scholarly study sector has been driven by the increased application of anatomical pathology processes in studies like tumor examination and biomarker profiling.

The shift from standard to custom medicine has led to the fastest growth of the drug discovery and development sector. This is mainly because findings of alleged biomarkers are increasingly being relied upon to develop personalisation.

The biggest share of hospitals has been contributed by increasing hospitalization rates which stimulates the implementation of pathological workflows for disease monitoring and diagnosis.

On the other side, the development of the diagnostic lab segment is enhanced by the use of advanced laboratory devices and instruments, various electronic interfaces and IT systems.

In addition to a big amount of government financing programs, the presence of important players like Thermo Fisher and Agilent contributes to the biggest proportion in North America.

Asia Pacific is anticipated to show the highest development in the industry of anatomic pathology driven by the existence of numerous organizations involved in pathology practice.

The diagnosis of multiple infectious diseases, multiple cancer types as well as medical circumstances involves anatomical pathology by examining tissues and cells samples from the biopsy report. Increasingly aging, chronic illnesses are on the rise, and expensive healthcare are all showing favorable development in this industry. This has recently improved the need for the market for anatomic pathology. In the coming years, the nations with the highest amount of older populations will develop the market for anatomical pathology. Technological advances will also function as the driving force for this industry in the healthcare industry.

Key Players amp; Strategies

Some of the key players are Laboratory Corporation of America Holdings; Thermo Fisher Scientific, Inc.; Sakura Finetek USA, Inc.Cardinal Health, Inc.; Agilent Technologies, Inc.; F. Hoffmann-La Roche AG; Quest Diagnostics Incorporated; BioGenex; NeoGenomics Laboratories, Inc.; and Bio SB.

These main players implement various approaches in order to retain their important market share during the forecast period. Collaborative development, corporate development and product development are the strategies introduced.

For instance, in June 2018, Agilent Technologies introduced a range of probes, such as MALT1, MYC, BCL6, BCL2, CCND1, IGH, IGH / BCL2, IGH / MYC, and IGH /CCND1, for in situ hybridization. The launch of these products has improved the portfolio of the company and thus reinforced its place in the industry.

View Full Report at https://www.acumenresearchandconsulting.com/anatomic-pathology-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Anatomic Pathology
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Anatomic Pathology Market By Product and Service
1.2.2.1. Global Anatomic Pathology Market Revenue and Growth Rate Comparison By Product and Service (2015-2026)
1.2.2.2. Global Anatomic Pathology Market Revenue Share By Product and Service in 2017
1.2.2.3. Consumables
1.2.2.3.1. Reagents amp; Antibodies
1.2.2.3.2. Probes amp; Kits
1.2.2.3.3. Others
1.2.2.4. Instruments
1.2.2.4.1. Tissue processors
1.2.2.4.2. Automatic Stainers
1.2.2.4.3. Microtomes amp; Cryostat
1.2.2.4.4. Others
1.2.2.5. Services
1.2.3. Anatomic Pathology Market By Application
1.2.3.1. Global Anatomic Pathology Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Drug Discovery amp; Development
1.2.3.3. Disease Diagnosis
1.2.3.4. Others
1.2.4. Anatomic Pathology Market By End-use
1.2.4.1. Global Anatomic Pathology Market Revenue and Growth Rate Comparison By End-use (2015-2026)
1.2.4.2. Hospitals
1.2.4.3. Diagnostic Laboratories
1.2.4.4. Research Laboratories
1.2.4.5. Others
1.2.5. Anatomic Pathology Market by Geography
1.2.5.1. Global Anatomic Pathology Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Anatomic Pathology Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Anatomic Pathology Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Anatomic Pathology Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Anatomic Pathology Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Anatomic Pathology Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Anatomic Pathology Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Anatomic Pathology Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Product and Service of Global Anatomic Pathology Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Anatomic Pathology Major Manufacturers in 2017

CHAPTER 4. ANATOMIC PATHOLOGY MARKET BY PRODUCT AND SERVICE

4.1. Global Anatomic Pathology Revenue By Product and Service
4.2. Consumables
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.3. Reagents amp; Antibodies
4.2.4. Probes amp; Kits
4.2.5. Others
4.3. Instruments
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3.3. Tissue processors
4.3.4. Automatic Stainers
4.3.5. Microtomes amp; Cryostat
4.3.6. Others
4.4. Services
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. ANATOMIC PATHOLOGY MARKET BY APPLICATION

5.1. Global Anatomic Pathology Revenue By Application
5.2. Drug Discovery amp; Development
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Disease Diagnosis
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. ANATOMIC PATHOLOGY MARKET BY END-USE

6.1. Global Anatomic Pathology Revenue By End-use
6.2. Hospitals
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Diagnostic Laboratories
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Research Laboratories
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Others
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA ANATOMIC PATHOLOGY MARKET BY COUNTRY

7.1. North America Anatomic Pathology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Anatomic Pathology Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. U.S.
7.3.1. U.S. Anatomic Pathology Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE ANATOMIC PATHOLOGY MARKET BY COUNTRY

8.1. Europe Anatomic Pathology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Anatomic Pathology Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET BY COUNTRY

9.1. Asia-Pacific Anatomic Pathology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Anatomic Pathology Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA ANATOMIC PATHOLOGY MARKET BY COUNTRY

10.1. Latin America Anatomic Pathology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Anatomic Pathology Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST ANATOMIC PATHOLOGY MARKET BY COUNTRY

11.1. Middle East Anatomic Pathology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Anatomic Pathology Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA ANATOMIC PATHOLOGY MARKET BY COUNTRY

12.1. Africa Anatomic Pathology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Anatomic Pathology Market Revenue Share Comparison, 2015 amp; 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Boehringer Ingelheim GmbH
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Lonza
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Rentschler Biotechnologie GmbH
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. JRS Pharma (Celonic GmbH)
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. TOYOBO Biologics, LTD
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. FUJIFILM Diosynth Biotechnologies U.S.A.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Patheon
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. CMC Biologics
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. WuXi Biologics
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Others
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

Request for Customization at https://www.acumenresearchandconsulting.com/request-customization/1525

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/1525

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 19-Jul-2019